Nova Scotia Mi’kmaq First Nations, Halef Group, and MJardin Expect Sales License this Spring
TORONTO and DENVER, April 18, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce that its joint-venture AtlantiCann Medical Inc. (“AMI”) facility located in Lower Sackville, Nova Scotia has now reached its full production capacity in an impressive four months since receiving its cultivation and processing license on December 7, 2018. AMI is a three-way joint-venture consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).
Phase 1 of the AMI complex is a 48,000 square foot cultivation and extraction facility with a full production capacity of 4,700 kg of flower and trim. In just four months since the AMI team received its cultivation license, the facility has propagated all flower rooms with a total of 6,000 plants, 3,600 of which are currently in flower stage. Phase 2 of the AMI complex will expand production to approximately 8,550 kg of flower and trim by adding another 20,000 square feet of capacity.
“The impressive turnaround time to reach full production capacity at AMI is a testament to the skilled experts we have within our Company and our dedicated team in Lower Sackville,” noted Christine Halef, SVP of Atlantic Canada Operations. “MJardin is drawing from 10 years of hands on experience cultivating premium cannabis with high yields in the United States.”
“We are very pleased with the progress that the AMI team has already made in Nova Scotia and the speed at which our facility is moving,” noted Chief Terrance Paul, Co-Chair of the Assembly of Nova Scotia Mi’kmaq Chiefs. “We performed a high degree of due diligence to find the right partners, and this latest milestone is a reflection of our confidence in MJardin’s experience, knowledge and capabilities.”
The AMI complex is currently working towards its Good Manufacturing Practices (“GMP”) certification which would allow for product export to international markets. Additionally, extraction capabilities are expected to be implemented in Q4 of 2019 in time for the legalization of additional cannabis products.
About MJardin Group
MJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com.
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
